Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic potential of exosomes from adipose-derived stem cells in chronic wound healing. | Front Surg | 2022 | 36248361 | PubTator, text mining | PubMed |
| Reprogramming of cancer-associated fibroblasts by apoptotic cancer cells inhibits lung metastasis via Notch1-WISP-1 signaling. | Cell Mol Immunol | 2022 | 36241874 | PubTator, text mining | PubMed |
| CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma. | Front Immunol | 2022 | 36238304 | PubTator, text mining | PubMed |
| Implications of notch signaling in duchenne muscular dystrophy. | Front Physiol | 2022 | 36237531 | PubTator, text mining | PubMed |
| Molecular Mechanisms Underlying Pathological and Therapeutic Roles of Pericytes in Atherosclerosis. | Int J Mol Sci | 2022 | 36232962 | PubTator, text mining | PubMed |
| Progress and Current Status in Hajdu-Cheney Syndrome with Focus on Novel Genetic Research. | Int J Mol Sci | 2022 | 36232677 | PubTator, text mining | PubMed |
| High-Resolution Conformational Analysis of RGDechi-Derived Peptides Based on a Combination of NMR Spectroscopy and MD Simulations. | Int J Mol Sci | 2022 | 36232339 | PubTator, text mining | PubMed |
| Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer. | Cancer Cell Int | 2022 | 36229883 | PubTator, text mining | PubMed |
| A nine-consensus-prognostic -gene-based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies. | Front Genet | 2022 | 36226177 | PubTator, text mining | PubMed |
| Targeting extracellular matrix remodeling sensitizes glioblastoma to ionizing radiation. | Neurooncol Adv | 2022 | 36212741 | PubTator, text mining | PubMed |
| HIF-2α regulates proliferation, invasion, and metastasis of hepatocellular carcinoma cells via VEGF/Notch1 signaling axis after insufficient radiofrequency ablation. | Front Oncol | 2022 | 36212390 | PubTator, text mining | PubMed |
| Sirtuin1 meditated modification of Notch1 intracellular domain regulates nucleolar localization and activation of distinct signaling cascades. | Front Cell Dev Biol | 2022 | 36211456 | PubTator, text mining | PubMed |
| Stem cell-based multi-tissue platforms to model human autoimmune diabetes. | Mol Metab | 2022 | 36209784 | PubTator, text mining | PubMed |
| Signaling pathways and therapeutic interventions in gastric cancer. | Signal Transduct Target Ther | 2022 | 36209270 | PubTator, text mining | PubMed |
| Prognostic Index for Nonsmall Cell Lung Cancer Based on Immune-Related Genes Expression. | Biomed Res Int | 2022 | 36193311 | PubTator, text mining | PubMed |
| The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer. | Breast Cancer (Dove Med Press) | 2022 | 36193236 | PubTator, text mining | PubMed |
| Notch signaling functions in noncanonical juxtacrine manner in platelets to amplify thrombogenicity. | Elife | 2022 | 36190110 | PubTator, text mining | PubMed |
| Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. | Front Mol Biosci | 2022 | 36188225 | PubTator, text mining | PubMed |
| Atypical induction of HIF-1α expression by pericellular Notch1 signaling suffices for the malignancy of glioblastoma multiforme cells. | Cell Mol Life Sci | 2022 | 36183290 | PubTator, text mining | PubMed |
| A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma. | Nat Commun | 2022 | 36180422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=41